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Abstract
Objective:  To investigate differences in pre- and postoperative patient-relevant outcome
between hybrid total hip replacement (THR) and cemented THR in patients with primary
osteoarthritis (OA).
Methods: 245 consecutive patients were included in the study. 68 of the patients (mean age 62)
were operated on with hybrid THR and 177 (mean age 74) were operated on with cemented THR.
All patients were investigated preoperatively and 0.5, 1 and 3.6 years postoperatively with two self-
administered questionnaires, SF-36 and WOMAC (Western Ontario and MacMaster Universities
Osteoarthritis Index, LK 3.0).
Results: Preoperatively, there was a difference in the SF-36 subscales RP (role physical) and GH
(general health) where the patients with the hybrid THR attained better scores. At 3.6-years the
patients with the hybrid THR reached better scores in all SF-36 subscales except BP (bodily pain)
and GH. Further, they had better scores in WOMAC function. However, after adjusting for age,
sex, follow-up time and baseline values there were no differences in outcome between the two
different surgical techniques.
Conclusion: This medium term (3–5 years), controlled, open cohort study, using patient-relevant
outcome measures, did not reveal any differences between hybrid THR and cemented THR for OA
at 3.6 years after surgery. Since the study had 75–94% power to detect the clinically significant
score difference of 10 points, we suggest that any difference in outcome between these two
methods is small and may require a large-scale, blinded, randomized trial to show.
Introduction
Since the development of total hip replacement (THR)
there has been a wish to evaluate the results of the inter-
vention. Approximately 20 different hip scores have been
introduced [1]. The variables measured have been pain,
walking distance, use of walking assistance, range of
motion, ability to put on shoes, climb stairs, use of public
transport, etc. Inconsistent results have been found when
comparing outcomes with scores which used descriptive
terms such as excellent, good or failure, whereas there was
better correlation between outcomes when using different
numerical scores [1]. Callaghan et al. [2] compared five
different rating systems and found no uniformity in the
results between ratings, nor any uniformity between the
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ratings and the patients impressions. In particular, a
marked disparity has been shown between the patient's
and the physician's scores after THR [3]. It is therefore
important and necessary to take into consideration the
patient's point of view when evaluating health status and
outcome after this intervention.
At the OMERACT conference 1997 a core set of outcome
measures was established for joint disease. Four domains
were to be evaluated: pain, physical function, patient glo-
bal assessment and joint imaging. Crucial importance was
attached to patient-relevant measures [4]. The informa-
tion in patient-relevant measures relies exclusively on the
information provided by the patient, generally collected
by questionnaires, either self-administered or adminis-
tered by interviewers.
The definition for failure used in most large joint replace-
ment registries is surgical revision (exchange or removal
of the implant) [5,6]. However, surgical revision as a def-
inition of outcome failure does not fully consider the
patient's point of view, and outcomes based on surgical
revision or questionnaire-based data provided by the
patient differ significantly [7]. However, there are few or
no studies comparing different surgical techniques or
joint implants, where validated and patient-relevant out-
come measures have been used as the primary outcome.
Considerable difficulties are associated with the design
and practise of controlled, randomized trials of surgical
interventions [8,9]. These problems are particularly evi-
dent for methods that have already reached clinical prac-
tise, where the surgeon's and sometimes the patient's lack
of equipoise can make recruitment into a randomized
trial very difficult [10].
A large number of different implant configurations for
THR have been introduced into the market, often in the
absence of controlled trials. 'Hybrid' THR designs, where
an uncemented acetabular cup is used with a cemented
femoral stem, have seen increased recent use. This config-
uration is sometimes preferred for younger patients, in the
belief that this cup configuration will provide less risk for
loosening and easier revision [11]. However, little or no
information based on patient-relevant outcomes exist to
guide the surgeon in the choice of implant for the younger
patient.
With knowledge of the difficulties and costs associated
with blinded, randomized trials in this area, we have per-
formed a prospective, controlled open cohort study com-
paring hybrid THR with traditional cemented THR, using
patient-relevant outcomes. The purpose was to investigate
differences in postoperative medium term outcome
between these two groups. Results from open studies such
as this provide a basis for assessing the need for larger,
randomized and blinded trials.
Patients and Methods
Two-hundred and forty-five patients (133 women, 112
men) with a mean age at time of surgery of 69 years (50–
92) were included in the study (Fig. 1).
All patients were assigned for THR because of primary
osteoarthritis (OA). The patients were consecutively
included during September 1995 to October 1998 at the
Department of Orthopaedics in Halmstad, Sweden. All
patients had a primary unilateral THR performed.
68 patients (29 women, 39 men) with a mean age at time
of surgery of 62 years (50–72) were operated with a
hybrid THR. The THR were performed using the unce-
mented Trilogy (N = 62) or HGC (N = 6) acetabular com-
ponent (Zimmer®) and the cemented Lubinus SP II (N =
55) (Link®) or Anatomic (N = 13) (Zimmer®) femoral
component. All acetabular components were fixed with
bone screws. The incision was either antero-lateral or pos-
tero-lateral. The femoral component was inserted with a
second generation cementing technique, which includes
the use of a medullary plug, a cement gun to introduce
cement in a retrograde fashion and pressurization of the
cement. The indication for hybrid THR instead of
cemented THR was principally a younger age of the
patient. Another important reason for the decision was
the competence of the surgeon and his personal opinion
about the method.
177 of the patients (104 women, 73 men), received a
cemented Lubinus acetabular component and a cemented
Lubinus SP II femoral component was used as a reference
group. Their mean age at time of surgery was 75 (61–92).
Seven different surgeons were involved, all experienced
hip surgeons. One of them made one third of the hybrid
THR. The patients were evaluated preoperatively, at 3, 6,
12 months and at 3.6 years (26–65 months, mean 43
months, median 40 months) after the index THR surgery.
Patients with the hybrid prosthesis were advised to par-
tially bear weight for the first 8 weeks after surgery,
whereas patients with cemented prosthesis were full
weight bearing. Surgical technique, cementing technique,
rehabilitation and follow-up evaluation was otherwise all
identical for both groups.
The preoperative hip radiographs were classified by one
radiologist according to OARSI criteria with a radio-
graphic atlas as a guide [12]. OA was graded from 0–3 in
accordance with the joint space narrowing where 3 indi-
cates severe OA. 45 patients had severe OA and 19 moder-
ate OA in the hybrid group and 109 patients had severeHealth and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/21
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OA and 40 moderate in the cemented group (the radio-
graphs for 4 patients were not found).
Questionnaires
SF-36
Evaluation with SF-36 was made at the hospital the day
before operation and three, six and twelve months post-
operatively. The SF-36 measures three major health
attributes (functional status, well being, overall health) in
eight subscales. These include (1) physical function, (2)
role limitations due to physical health, (3) bodily pain,
(4) general health, (5) vitality, (6) social function, (7) role
limitations due to emotional health and (8) mental
health [13]. The SF-36 scores are calculated on 0–100
worst to best scale. Together, the eight subscales provide a
health profile. SF-36 is translated and validated for Swed-
ish conditions [14]. It has previously been used in follow
up studies of THR [15,16].
Figure 1
Flowchart showing the number of patients included in the beginning of the study and excluded at the 1 year and 3.6 years (26–
65 months) follow-up.Health and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/21
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WOMAC
WOMAC (Western Ontario and McMaster Universities
Osteoarthritis Index, LK 3.0) was used as the disease spe-
cific instrument. Evaluation with WOMAC was made pre-
operatively, three, six and twelve months postoperatively.
However, since this instrument was not available and val-
idated for Swedish conditions when the study was initi-
ated, it was used at baseline for the last 92 patients only.
There were no differences concerning age and sex between
these 92 patients and the 106 that were included earlier.
WOMAC is a self-administered instrument validated for
OA in the lower extremities and for evaluating outcome
after THR [17,18]. It consists of twenty-four multiple-
choice items grouped into three categories: pain (five
questions), stiffness (two questions), and physical func-
tion (seventeen questions). It is reliable and valid for
Swedish conditions [19]. To make comparisons easier
with SF-36, WOMAC was transformed to 0–100 worst to
best scale [19–21].
In the measurement of outcome it is desirable to include
both a generic instrument and a disease specific instru-
ment [22–24]. Thus, both SF-36 and WOMAC were cho-
sen for this study.
Additional Questions
Questions about postoperative complications, and preop-
erative and postoperative comorbidity, were asked at the
3.6 year follow-up.
Postoperative complications
Three questions were asked about serious postoperative
complications; dislocation of the prosthesis, deep infec-
tion in the hip joint and reoperation. The self reported
data was compared with data from the patients' case
records.
General co-morbidity
Fourteen questions were asked about intercurrent diseases
preoperatively and in the present situation [16,25]. Ques-
tions were asked for the presence of 12 co-morbid condi-
tions or body areas with problems (heart, hypertension,
peripheral arteries, lung, diabetes, neurological problems,
cancer, ulcer, kidney disease, vision, back pain, and psy-
chiatric disease). The questions were multiple choice (yes,
no, don't know). The total number of conditions or prob-
lems reported was used as a summary variable (0, 1, 2 or
more), a method shown to be valid in this kind of follow-
up [16].
Musculoskeletal co-morbidity
Two questions were asked about the need of walking
assistance and walking distance, preoperatively and in the
present situation [26], two questions were asked about the
need of analgesics due to pain in the operated hip joint or
due to pain elsewhere. One question was asked about the
experience of regional or widespread pain lasting more
than 3 months during the last 12 months [25]. One ques-
tion was asked about joint replacement in the contra-lat-
eral hip or in the knees since the THR. The last questions
concerned fractures in the spine, wrist, hip or elsewhere.
Statistics
Statistical analysis was done with the SPSS 10.0 package.
For comparison between two subgroups Mann-Whitney
test was used. For comparing the frequency of co-morbid-
ities in subgroups chi-square test was used. The results
were adjusted for age, sex, follow-up time and baseline
values with a multivariate logistic analysis of regression.
Results
Of the 245 patients 28 were excluded during the first fol-
low up year, 14 had surgery on the contra-lateral side, 8
declined to participate, 3 had died, 2 had recurrent dislo-
cations and 1 could not participate because of difficulties
with the language. At the final follow-up 13 patients
declined to participate and 8 had died since the one year
follow-up. Thus the result of 196 patients (105 women,
91 men) with a mean age at surgery of 68 years (50–88)
are presented (Fig 1). Of those 57 were operated on with
hybrid THR and 139 with cemented THR.
Major postoperative complications
Two patients had been re-operated after the first follow-up
year (one patient was re-operated due to recurrent hip
implant dislocations and one due to a deep infection).
Another three patients suffered from recurrent disloca-
tions after the first follow-up year and one of those also
sustained an infection. None of these patients were oper-
ated on with the hybrid technique. At the 3.6 year follow-
up there was no difference in the three WOMAC subscales
between the patients with and without major postopera-
tive complications (data not shown).
The frequency of comorbidity
There were no differences in the frequency of co-morbidi-
ties preoperatively between the patients operated with the
hybrid technique and the patients operated with the
cemented technique. Neither were there any differences
between the two groups at the 3.6 year follow up.
The frequency of musculoskeletal comorbidity
The patients with cemented THR used walking assistance
in a higher frequency than those with hybrid implants
both preoperatively (hybrid 16/56, cemented 77/136, p <
0.001) and at the 3.6 year follow-up (hybrid 8/56,
cemented 60/136, p < 0.0001). There was also a difference
in the walking distance preoperatively were the patients
operated with the hybrid technique reported a higher fre-
quency of a walking distance more than 3 km than theHealth and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/21
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patients operated with the cemented technique (hybrid
28/56, cemented 39/135, p = 0.005). The walking dis-
tance at the 3.6 year follow-up also differed between the
two groups with an advantage for the patients operated
with the hybrid technique (hybrid 46/54, cemented 82/
134, p = 0.001).
There was no difference between the two groups concern-
ing the consumption of analgesics against pain from the
operated hip (hybrid 15/56, cemented 38/137) or pain
with another origin (hybrid 24/55, cemented 64/135).
The patients operated with the cemented technique in a
higher degree reported pain from the knees at the 3.6 year
follow-up (hybrid 5/57, cemented 31/139, p = 0.026).
There was no difference concerning regional pain (hybrid
33/54, cemented 83/129) or widespread pain (hybrid 3/
24, cemented 10/56) between the two groups.
Comparison between outcomes of hybrid and cemented 
techniques
Preoperatively, there were no differences in the WOMAC
subscales pain, stiffness or physical function between the
patients operated with hybrid technique and the patients
operated with cemented technique (Table 2). Neither
were there any differences in the SF-36 subscales, except
RP (role physical) and GH (general health) between the
two groups at this time (Table 1). At 12 months after sur-
gery the patients operated on with hybrid technique
reached better scores in all the SF-36 subscales except BP
(bodily pain), (Table 1) and a better score in WOMAC
physical function (p = 0.014) (Table 2). At 3.6 years fol-
low-up the patients operated on with hybrid technique
reached better scores in all SF-36 subscales except BP and
GH (Table 2) and a better score in WOMAC physical func-
tion (p = 0.001) (Table 2). The difference in mean age
between these two groups, 12.3 years (61.9 vs. 74.2), was
significant.
Comparison of hybrid and cemented technique after 
adjusting for age, sex, follow up time and baseline values
In the univariate analysis the OR for SF-36 PF and
WOMAC function was significant (Table 3). After
adjusting for age, sex, follow up time and baseline values
by using a multivariate logistic regression analysis at the
3.6 year follow up, there were no differences between the
two surgical techniques in the outcome of SF-36 PF and
WOMAC function (Tables 4,5). It should be noted that
the odds ratios are expressed per one year or scale unit dif-
ference. Neither were there any differences in the other SF-
36 subscales or WOMAC dimensions (data not shown).
Discussion
This prospective study did not reveal any differences in
patient-relevant outcomes between patients operated on
with cemented technique or hybrid technique in either
preoperative or postoperative health-related quality of life
at the 3.6 year (26–65 months) follow-up, when the
results had been adjusted for age, sex, follow-up time and
baseline values.
The frequency of comorbidities did not differ between the
two groups of patients although one of the groups was sig-
nificantly younger. That may be due to the fact that
relatively healthy patients are assigned for THR. This is
consistent with previous observations in that OA is not
predictive for development of future co-morbidities
[16,27].
Table 1: SF-36 results before, and at one year and 3.6 years (26–65 months) after THR for OA. Mean scores and (standard deviations) 
of the SF-36 subscales for patients operated on with cemented total hip replacement (81 women), mean age 74 (61–88) and hybrid total 
hip replacement (24 women) mean age 62 (50–72).
SF-36 subscale Preop 
Cemented
(N = 139)
Preop Hybrid 
(N = 57)
1 year Postop 
Cemented
(N = 139)
1 year Postop 
Hybrid
(N = 57)
3.6 year Postop 
Cemented
(N = 139)
3.6 year Postop 
Hybrid
(N = 57)
PF 30.43 (20.4) 30.4 (17.7) 61.6 (22.4) *74.2 (19.7) 56.5 (24.2) *68.2 (25.3)
RP 6.8 (17.1) *15.5 (28.7) 51.7 (42.3) *72.4 (37.1) 39.7 (42.9) *63.9 (41.6)
BP 30.5 (15.6) 30.3 (20.0) 72.3 (24.9) 78.0 (21.7) 64.9 (25.6) 69.2 (27.9)
GH 66.4 (19.6) *72.4 (20.3) 68.9 (20.5) *78.7 (21.6) 64.4 (21.1) 70.1 (23.9)
VT 47.8 (21.3) 51.2 (20.2) 68.7 (22.0) *78.0 (20.8) 61.0 (24.0) *70.0 (24.1)
SF 62.6 (26.5) 67.0 (25.3) 84.7 (23.5) *92.7 (17.2) 81.0 (23.0) *90.6 (20.5)
RE 33.6 (41.0) 43.8 (44.3) 63.3 (40.7) *86.3 (29.2) 56.8 (44.0) *83.6 (32.0)
MH 68.3 (19.8) 71.6 (23.8) 80.2 (19.3) *87.3 (15.7) 76.5 (19.8) *83.4 (20.1)
* = p < 0.05 hybrid vs. cemented THR for each observation time. PF-physical function, RP-role physical, BP-bodily pain, GH-general health, VT-vital-
ity, SF-social function, RE-role emotional, MH-mental health. The scale is 0–100, worst to best.Health and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/21
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A limitation of the study is the variable follow-up time.
Thus, the patients with the longest follow-up time have
reached a higher age than the patients with a shorter fol-
low-up time. On the other hand, these patients have had
longer time for rehabilitation and recovery. However,
there was no difference between the surgical procedures
when adjusted for follow-up time.
We have in this study described outcomes after THR for
unilateral OA in an orthopaedic department at a general
hospital. Patient mix and selection varies between differ-
ent hospitals, which may influence outcome [28]. The
patient groups compared in this study were of limited
size. However, with the high responsiveness of the out-
come measures SF-36 and WOMAC after THR [29,30]
only a small sample size is required for statistical calcula-
tions. A power analysis of the present study thus resulted
in a power of 75–94% to detect a difference of 10 points,
assuming a standard-deviation of 15 and a significance
level of 0.05. The reason for the choice of an absolute
Table 2: WOMAC before, and at one year and 3.6 years (26–65 months) after THR for OA. Mean scores and (standard deviations) of 
the three WOMAC subscales for all patients investigated and operated on with cemented total hip replacement and hybrid total hip 
replacement. The scale is 0–100, worst to best.
WOMAC 
subscale
Preop 
Cemented
(N = 65)
Preop Hybrid 
(N = 29)
1 year Postop 
Cemented
(N = 90)
1 year Postop 
Hybrid
(N = 42)
3.6 years Postop 
Cemented
(N = 139)
3.6 years Postop 
Hybrid
(N = 57)
Pain 45.3 (17.9) 44.8 (15.9) 84.4 (17.1) 84.1 (18.1) 81.0 (20.1) 84.2 (21.0)
Stiffness 37.7 (16.6) 42.0 (15.7) 75.8 (20.5) 81.8 (16.6) 76.1 (22.0) 80.7 (22.3)
Function 37.1 (15.5) 41.8 (12.5) 75.4 (18.0) 83.0 (16.1) 71.3 (21.7) *81.2 (20.4)
* = p < 0.05 hybrid vs. cemented THR for each observation time.
Table 3: Univariate and multivariate logistic regression analysis comparing follow-up data (26–54 months) for SF-36 PF (physical 
function) and WOMAC function in patients operated on with hybrid or cemented technique (dependent variables) adjusted for age, 
sex, follow-up time and baseline values (explanatory variables) in the multivariate analysis.
variable N Univariate OR 95% CI p-value
Age 198 *0.62 0.53–0.72 <0.01
Sex 198 0.52 0.28–0.97 0.04
Follow-up time 198 0.99 0.96–1.02 0.49
SF-36 PF baseline 196 1.00 0.98–1.02 0.98
SF-36 PF follow-up 196 *1.02 1.00–1.03 <0.01
WOMAC function baseline 196 1.02 0.99–1.05 0.16
WOMAC function follow-up 94 *1.02 1.00–1.04 <0.01
*per one year or scale unit increase. OR less than 1 means that with increasing age there is a less probability of being operated with hybrid tech-
nique. OR = odds ratio, 95% CI = 95% confidence interval
Table 4: Univariate and multivariate logistic regression analysis comparing follow-up data (26–54 months) for SF-36 PF (physical 
function) and WOMAC function in patients operated on with hybrid or cemented technique (dependent variables) adjusted for age, 
sex, follow-up time and baseline values (explanatory variables) in the multivariate analysis.
variable N Multivariate OR 95% CI p-value
Age 198 *0.57 0.48–0.69 <0.01
Sex 198 0.29 0.08–1.06 0.06
Follow-up time 198 0.96 0.90–0.16 0.16
SF-36 PF baseline 196 *0.95 0.91–0.99 <0.01
SF-36 PF follow-up 196 1.03 0.98–1.06 0.07
*per one year or scale unit increase. OR less than 1 means that with increasing age there is a less probability of being operated with hybrid tech-
nique. OR = odds ratio, 95% CI = 95% confidence intervalHealth and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/21
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change of 10 score units is the knowledge that in clinical
trials of rehabilitation intervention and medical treatment
of OA the smallest clinically significant improvement in
WOMAC function and pain is 9–12 score units [31,32].
We have not found any published randomized studies
comparing cemented and hybrid THR, using patient-rele-
vant outcome measures. Had we found differences
between the two study groups in the present open study,
this would have provided a rationale for a blinded, rand-
omized study. The absence of difference between the
study groups in this prospective, open cohort study com-
paring hybrid and cemented THR suggests that any differ-
ence in patient-relevant outcome and health-related
quality of life between these two techniques will be small,
and require a large randomized trial to prove. However,
recently introduced techniques such as hybrid THR
should continue to be monitored to determine long-term
patient-relevant outcome, including health-related qual-
ity of life, as well as implant survival.
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